Significant Borrow Rate Increases Among Liquid Option Names
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 13 2026
0mins
Should l Buy BYND?
Latest data shows the largest indicative borrow rate increases among liquid option names include: DEFIANCE DAILY TARGET 2X LONG RIOT ETF (RIOX) 29.56% +2.00, NovaDel Pharma (NVDL) 4.27% +1.10, Beyond Meat (BYND) 12.80% +0.91, ProShares UltraPro Short S&P 500 (SPXU) 9.35% +0.84, Offerpad Solutions (OPAD) 43.76% +0.72, Fly Leasing Ltd (FLY) 12.72% +0.68, Defiance Daily Target 2X Long HIMS ETF (HIMZ) 26.67% +0.62, T-REX 2X INVERSE MSTR DAILY TARGET (MSTZ) 36.50% +0.52, Vici Properties (VICI) 0.76% +0.48, and Direxion Daily Small Cap Bear 3X Shares (TZA) 6.62% +0.43.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy BYND?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on BYND
Wall Street analysts forecast BYND stock price to rise
4 Analyst Rating
0 Buy
1 Hold
3 Sell
Moderate Sell
Current: 0.610
Low
0.80
Averages
0.93
High
1.00
Current: 0.610
Low
0.80
Averages
0.93
High
1.00
About BYND
Beyond Meat, Inc. is a plant-based meat company offering a portfolio of plant-based meats. The Company sells a range of plant-based meat products across its three core platforms of beef, pork and poultry. The primary components of animal-based meat are amino acids, lipids, carbohydrates, trace minerals and water, which are not exclusive to animals and are plentiful in plants. Its beef platform products contain protein primarily derived from one or a combination of pea protein, rice protein, faba bean protein and wheat gluten. Its pork platform products include Beyond Sausage, Beyond Breakfast Sausage Patties, Beyond Breakfast Sausage Links and Beyond Sausage Crumbles. Its poultry platform consists of products that mimic animal-based chicken in its various merchandised forms, including chicken tenders, chicken nuggets and popcorn chicken. Its primary products under its poultry platform include Beyond Chicken Tenders, Beyond Chicken Nuggets and Beyond Popcorn Chicken.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Beyond Meat Reports Q4 Net Income Reversal
- Net Income Reversal: Beyond Meat reported a net income of $409.9 million in Q4, a significant turnaround from a net loss of $44.9 million in the same period last year, indicating a strong recovery capability in its financial performance.
- Earnings Per Share Growth: The basic earnings per share rose to $0.84 from a loss of $0.65 a year ago, reflecting a shift in profitability, although the diluted loss per share of $0.29 highlights the complexity of earnings quality amid ongoing challenges.
- Revenue Decline: Net revenues fell to $61.6 million, down 19.7% year-over-year, primarily due to a 22.4% decrease in product volume sold, indicating market demand challenges, although a 3.5% increase in net revenue per pound partially mitigated this impact.
- Debt Restructuring Gain: The net income included a $548.7 million non-cash gain from debt restructuring, showcasing the company's efforts in optimizing its financial structure, although the core business still faces challenges that warrant attention for sustainability going forward.
See More
Beyond Meat Reports Earnings Miss, Debt Reduction Provides Limited Relief
- Earnings Miss: Beyond Meat reported a GAAP EPS of -$0.29, missing expectations by $0.21, indicating ongoing challenges in profitability that may erode investor confidence.
- Revenue Shortfall: The company's revenue of $61.59M fell short of the anticipated $62M, reflecting weak consumer demand and intensified market competition, which exacerbates financial pressures.
- Debt Reduction Impact: While the company has managed to reduce some debt, this only provides a temporary reprieve for its financial situation and fails to effectively reverse the overall operational difficulties, necessitating a search for sustainable growth strategies.
- Challenging Market Outlook: Beyond Meat continues to face significant challenges in the current economic climate, and investors should monitor how the company adapts to market changes and enhances product competitiveness to achieve long-term recovery.
See More
Beyond Meat Q4 Earnings Miss Expectations Amid Uncertainty
- Disappointing Earnings: Beyond Meat reported a Q4 GAAP EPS of -$0.29, missing expectations by $0.21, with revenue of $61.59 million reflecting a 19.7% year-over-year decline, indicating ongoing challenges in the current market environment.
- Cautious Outlook: The company projects Q1 2026 net revenues to be between $57 million and $59 million, falling short of the consensus estimate of $63.51 million, reflecting management's concerns over uncertainty impacting future performance.
- Negative Stock Reaction: Following the earnings report, Beyond Meat's shares fell 7.35% in after-hours trading, signaling heightened investor concerns regarding the company's future prospects, which could affect its financing capabilities and market confidence.
- Ongoing Debt Issues: Although the company has implemented debt reduction strategies to buy time, analysts note that these measures have not effectively reversed the company's struggles, necessitating close attention to its operational strategies and market adaptability moving forward.
See More
Multiple Companies Set to Report Earnings
- Nike Earnings Forecast: Nike (NKE) is expected to report an earnings per share of $0.29 for the quarter ending February 28, 2026, representing a 46.30% decrease compared to the same quarter last year, indicating increased competitive pressure despite beating expectations consistently over the past year.
- PVH Earnings Outlook: PVH is forecasting an earnings per share of $3.30 for the quarter ending January 31, 2026, reflecting a modest 0.92% increase year-over-year, demonstrating its stable market position as it has consistently exceeded market expectations in the past year.
- RH Earnings Growth: RH anticipates an earnings per share of $2.21 for the quarter ending January 31, 2026, marking a significant 39.87% year-over-year increase, showcasing strong business growth potential that may attract more investor interest.
- nCino Earnings Prediction: nCino expects an earnings per share of $0.06 for the quarter ending January 31, 2026, representing a remarkable 250.00% increase compared to the same quarter last year, which could help restore market confidence after previous underperformance.
See More
Surging Oil Prices Impact Market Sentiment
- Oil Price Volatility: Crude oil prices surged 55% in March following Trump's threat to 'take the oil in Iran,' marking the largest monthly gain ever, which has heightened concerns about the potential impact on the U.S. economy and market sentiment.
- Government Shutdown Impact: Trump signed an executive order to ensure TSA employees are paid after Congress failed to reach a deal, which may lead to longer security wait times and higher airfare for travelers, further affecting consumer confidence.
- Tech Industry Legal Risks: Meta's two courtroom defeats reveal the legal liabilities tech companies face when researching product impacts, which could have significant implications for the AI industry, prompting firms to reassess the risks versus rewards of such research investments.
- Pharmaceutical Collaboration: Eli Lilly's $2.75 billion deal with Insilico Medicine aims to bring AI-developed drugs to the global market, which not only boosted Lilly's stock price but also highlights the rapidly growing potential of AI applications in the pharmaceutical sector.
See More
Stock Futures Rise Amid Oil Price Surge and Market Recovery
- Oil Price Surge: Crude oil prices skyrocketed by 55% in March following Trump's threat to seize Iranian oil, marking the largest monthly gain ever, which pressures the U.S. economy and forces companies to adjust pricing strategies to cope with rising costs.
- Market Recovery Signal: Despite the S&P 500 and Nasdaq Composite experiencing their worst week of 2026, stock futures rose after Trump indicated “great progress” in negotiations with Iran, reflecting investor optimism about market recovery.
- TSA Employee Pay Restoration: Trump signed an executive order ensuring Transportation Security Administration employees will receive pay after Congress failed to reach a deal to end the government shutdown, alleviating traveler frustrations caused by long security wait times.
- AI Drug Development Partnership: Eli Lilly struck a $2.75 billion deal with Insilico Medicine to bring AI-developed drugs to market, enhancing Lilly's market confidence and potentially accelerating the application of AI in the pharmaceutical industry.
See More
Beyond Meat Reports Q4 Net Income Reversal
- Net Income Reversal: Beyond Meat reported a net income of $409.9 million in Q4, a significant turnaround from a net loss of $44.9 million in the same period last year, indicating a strong recovery capability in its financial performance.
- Earnings Per Share Growth: The basic earnings per share rose to $0.84 from a loss of $0.65 a year ago, reflecting a shift in profitability, although the diluted loss per share of $0.29 highlights the complexity of earnings quality amid ongoing challenges.
- Revenue Decline: Net revenues fell to $61.6 million, down 19.7% year-over-year, primarily due to a 22.4% decrease in product volume sold, indicating market demand challenges, although a 3.5% increase in net revenue per pound partially mitigated this impact.
- Debt Restructuring Gain: The net income included a $548.7 million non-cash gain from debt restructuring, showcasing the company's efforts in optimizing its financial structure, although the core business still faces challenges that warrant attention for sustainability going forward.
See More
Beyond Meat Reports Earnings Miss, Debt Reduction Provides Limited Relief
- Earnings Miss: Beyond Meat reported a GAAP EPS of -$0.29, missing expectations by $0.21, indicating ongoing challenges in profitability that may erode investor confidence.
- Revenue Shortfall: The company's revenue of $61.59M fell short of the anticipated $62M, reflecting weak consumer demand and intensified market competition, which exacerbates financial pressures.
- Debt Reduction Impact: While the company has managed to reduce some debt, this only provides a temporary reprieve for its financial situation and fails to effectively reverse the overall operational difficulties, necessitating a search for sustainable growth strategies.
- Challenging Market Outlook: Beyond Meat continues to face significant challenges in the current economic climate, and investors should monitor how the company adapts to market changes and enhances product competitiveness to achieve long-term recovery.
See More
Beyond Meat Q4 Earnings Miss Expectations Amid Uncertainty
- Disappointing Earnings: Beyond Meat reported a Q4 GAAP EPS of -$0.29, missing expectations by $0.21, with revenue of $61.59 million reflecting a 19.7% year-over-year decline, indicating ongoing challenges in the current market environment.
- Cautious Outlook: The company projects Q1 2026 net revenues to be between $57 million and $59 million, falling short of the consensus estimate of $63.51 million, reflecting management's concerns over uncertainty impacting future performance.
- Negative Stock Reaction: Following the earnings report, Beyond Meat's shares fell 7.35% in after-hours trading, signaling heightened investor concerns regarding the company's future prospects, which could affect its financing capabilities and market confidence.
- Ongoing Debt Issues: Although the company has implemented debt reduction strategies to buy time, analysts note that these measures have not effectively reversed the company's struggles, necessitating close attention to its operational strategies and market adaptability moving forward.
See More
Multiple Companies Set to Report Earnings
- Nike Earnings Forecast: Nike (NKE) is expected to report an earnings per share of $0.29 for the quarter ending February 28, 2026, representing a 46.30% decrease compared to the same quarter last year, indicating increased competitive pressure despite beating expectations consistently over the past year.
- PVH Earnings Outlook: PVH is forecasting an earnings per share of $3.30 for the quarter ending January 31, 2026, reflecting a modest 0.92% increase year-over-year, demonstrating its stable market position as it has consistently exceeded market expectations in the past year.
- RH Earnings Growth: RH anticipates an earnings per share of $2.21 for the quarter ending January 31, 2026, marking a significant 39.87% year-over-year increase, showcasing strong business growth potential that may attract more investor interest.
- nCino Earnings Prediction: nCino expects an earnings per share of $0.06 for the quarter ending January 31, 2026, representing a remarkable 250.00% increase compared to the same quarter last year, which could help restore market confidence after previous underperformance.
See More
Surging Oil Prices Impact Market Sentiment
- Oil Price Volatility: Crude oil prices surged 55% in March following Trump's threat to 'take the oil in Iran,' marking the largest monthly gain ever, which has heightened concerns about the potential impact on the U.S. economy and market sentiment.
- Government Shutdown Impact: Trump signed an executive order to ensure TSA employees are paid after Congress failed to reach a deal, which may lead to longer security wait times and higher airfare for travelers, further affecting consumer confidence.
- Tech Industry Legal Risks: Meta's two courtroom defeats reveal the legal liabilities tech companies face when researching product impacts, which could have significant implications for the AI industry, prompting firms to reassess the risks versus rewards of such research investments.
- Pharmaceutical Collaboration: Eli Lilly's $2.75 billion deal with Insilico Medicine aims to bring AI-developed drugs to the global market, which not only boosted Lilly's stock price but also highlights the rapidly growing potential of AI applications in the pharmaceutical sector.
See More
Stock Futures Rise Amid Oil Price Surge and Market Recovery
- Oil Price Surge: Crude oil prices skyrocketed by 55% in March following Trump's threat to seize Iranian oil, marking the largest monthly gain ever, which pressures the U.S. economy and forces companies to adjust pricing strategies to cope with rising costs.
- Market Recovery Signal: Despite the S&P 500 and Nasdaq Composite experiencing their worst week of 2026, stock futures rose after Trump indicated “great progress” in negotiations with Iran, reflecting investor optimism about market recovery.
- TSA Employee Pay Restoration: Trump signed an executive order ensuring Transportation Security Administration employees will receive pay after Congress failed to reach a deal to end the government shutdown, alleviating traveler frustrations caused by long security wait times.
- AI Drug Development Partnership: Eli Lilly struck a $2.75 billion deal with Insilico Medicine to bring AI-developed drugs to market, enhancing Lilly's market confidence and potentially accelerating the application of AI in the pharmaceutical industry.
See More
